期刊文献+

益气解毒方干预鼻咽癌细胞裸鼠移植瘤肿瘤微环境细胞免疫耐受现象的初步研究 被引量:8

Reliminary study on the effects of Qi-Boosting Toxin-Resolving Formula on the phenomenon of immune tolerance in the tumor microenvironment of grafted tumor with nasopharyngeal carcinoma cells among nude mice
下载PDF
导出
摘要 目的通过观察益气解毒方对鼻咽癌细胞裸鼠移植瘤的干预效应,探讨调节性T细胞诱导的鼻咽癌肿瘤微环境免疫耐受性特征及其对干预药物的反应性。方法人鼻咽癌细胞株CNE2细胞建立裸鼠移植瘤模型,然后随机分为模型组、益气解毒方治疗组、顺铂阳性对照组、益气解毒方与顺铂联合治疗组,每组8只动物,分别给予相应处理药物,系统观察各组裸鼠移植瘤生长情况及体积变化。观察期满后处死动物,取瘤体称重,分别计算抑瘤率,并切取瘤体组织标本,观察比较各组移植瘤的病理组织学变化,免疫组化法检测各组标本CD4、CD8、Foxp3表达活性,比较其组间差异。结果各组检测结果比较显示,益气解毒方处理后,移植瘤组织中的CD4、FoxP3表达活性受到明显抑制,CD8表达则明显提高,尤以联合治疗组表现明显,与模型组比较,组间差异具有显著性统计学意义。结论益气解毒方能有效改善鼻咽癌裸鼠移植瘤肿瘤微环境的免疫耐受现象而抑制肿瘤生长速度;联合应用化学药物后,该一效应尤为明显。 Objective To investigate the effect of Qi Boosting Toxin Resolving Formula (QBTRF) on the phenomenon of immune tolerance in the microenvironment of grafted tumor with nasopharyngeal carcinoma (NPC) cells (HNE2) among nude mice based on an in vivo experiment. Methods 2Thirty two BALB/c nude mice were used in this study to prepare grafted tumor models with human NPC cell line CNE2 by subcutaneously injecting method at first. Then, modeling mice were randomly divided into four groups, i.e. modeling group (MG) treated by orally taken normal saline, treating group (TG) treated with concentrated QBTRF solution, integrative treating group (ITG) with concentrated QBTRF solution and DDP injected peri/tonearly, and positive control group (PCG) treated by peri/tonearly injected DDP only, with 8 animals in each group. They were treated with corresponding treating procedures for 14 days respectively, when grafted tumors growing to a volumne about 1 cm in their diameter. Followed was observation on the dynamically growing status of grafted tumors during the experimental period among all groups. By the end of experimental period, all mice were put into death to dissect tumors for measuring the weight of grafted tumors to calculate the rate of tumor growinainhibiting and to take tissue samples from the dissected tumors for histopathological observation under light microscope respectively. Meanwhile, immunohistochemistry was made to detect the expressive levels of CD4,CD8 and Foxp3 in the cells of tumor tissues from all groups of animals. These results were also further confirmed by the procedures of Western blots. Results The inhibitory rates of tumor growing were 18.70%, 58.40% and 43.80% for TG, ITG and PCG respectively.Asdetermined by SABC immunohistochemistry followed by image analysis on these groups, the expressive activities of CD4 and Foxp3 were inhibited significantly in the samples of TG, ITG and PCG, while that of CD8 were obviously elevated in the tisuue samples of them (P0.01). These results were confirmed by the data of Western blotting assays Conclusion Qi Boosting Toxin Resolving Formula, especially when integreted with DDP, can effectively reverse the phenomenon of immune tolerance in the grafted tumor microenvironment of NPC among nude mice to induce a highly elevated tumor-inhibiting rate, with significantly improved quality of life.
出处 《中国中西医结合耳鼻咽喉科杂志》 2013年第1期10-15,21,共7页 Chinese Journal of Otorhinolaryngology in Integrative Medicine
基金 国家自然科学基金(No.81072904 30973856 81072904 30572408) 中国博士后科学基金(2011M501277) 湖南省外国专家局引智项目(湘财社指2011[40]号) 湖南省科技厅项目(2010SK3021) 湖南省中医药管理局项目(2010007 2011041) 湖南省2011年研究生创新基金(CX2011B335) 佛山市科技发展专项基金(No.FZ2010025)
关键词 鼻咽癌 肿瘤微环境 免疫耐受现象 益气解毒方 干预效应 Nasopharyngeal carcinoma immune tolerancegumor micrenvironment Qi-Boosting Toxin ResolvingFormula Intervention effect
  • 相关文献

参考文献5

  • 1Tuna B,Yorukoglu K,Gurel D,et al.Significance of COX 2 expression in human renal cell carcinoma [J]. Urology, 2004,64(6): 1116-1120.
  • 2Askenasy N,Kaminitz A,Yarkoni S.Mechanisms of T regulatory cell function.Autoimmun Rev May 2008,7(5).370 -375.
  • 3Askenasy N,Kaminitz A,Yarkoni S.Mechanism of T regulatory cell function.Autoimmun Rev, 2008,7:370 -375.
  • 4Suzuki M,Sugimoto A,Harashima A,Otani T, Yamamoto M,Nakamura S,Yamasaki F, Nishiyama M,Okazaki Y,Kibata M.Novel mechanisms of suppressor activity exhibited by cytotoxic regulatory T cell lines,HOZOT.Exp Hemat , 2009,37.92-100.
  • 5Andersson J,Tran DQ,Pesu M,Davidson TS, Ramsey H,O' Shea JJ,Shevach EM.CD4+ Foxp3+regulatory T ceils confer infectious dependent manner.J Exp tolerance in a TGKbeta Med,2008,205:1975-1981.

同被引文献80

  • 1王睿林,郑守曾.气虚体质与气虚证的关系探讨[J].辽宁中医杂志,2004,31(7):555-556. 被引量:24
  • 2王琦,高京宏.体质与证候的关系及临床创新思维[J].中医药学刊,2005,23(3):389-392. 被引量:99
  • 3王琦.9种基本中医体质类型的分类及其诊断表述依据[J].北京中医药大学学报,2005,28(4):1-8. 被引量:1982
  • 4王振瑞,李经纬,陈可冀.20世纪中国中西医结合研究的史学考察[J].中国中西医结合杂志,2005,25(11):1033-1037. 被引量:19
  • 5Liu H, Zhang W, Jia Y, et al. Single-cell clones of liver cancer stem ceils have the potential of differentiating into different types of tumor ceils. Cell Death Dis. 2013 Oct 17, 4. 857. doi. 10. 1038/cddis. 2013. 340.
  • 6Creighton C7, Gibbons DL, Kurie JM. The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective, Cancer Manag Res. 2013, 5: 187-195.
  • 7Droujinine IA, Eckert MA, Zhao W. To grab the stroma by the horns. From biology to cancer therapy with mesenchymal stem ceils. Oncotarget 2013 May: PMID: 23744479.
  • 8Atkinson RL, Yang WT, Rosen DG, et al. Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency. Breast Cancer Res. 2013, 15(5): 77.
  • 9Ahmed N, Stenvers KL. Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research. Front Oncol. 2013, 25(3): 256.
  • 10Creighton CJ, Gibbons DL, Kurie JM, The role of epithelial- mesenchymal transition programming in invasion and metastasis: a clinical perspective, Cancer Manag Res. 2013, 5: 187-195.

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部